LCS
CMD

Levin Capital Strategies’s Cantel Medical Corporation CMD Stock Holding History

Levin Capital Strategies’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,000
Closed -$158K – 442
2020
Q4 		$158K Buy
+2,000
New +$117K 0.02% 263

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Levin Capital Strategies's CMD Position: Q1 2021 in Review

Levin Capital Strategies sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 5,500 shares — an estimated $434K sold.

Levin Capital Strategies first reported a position in CMD in Q2 2020 and held it in 3 quarters. The position peaked at $509K in Q2 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Levin Capital Strategies reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Levin Capital Strategies sold 5,500 Cantel Medical Corporation shares in Q1 2021, an estimated $434K.
  • Levin Capital Strategies first reported a position in Cantel Medical Corporation in Q2 2020 and held it in 3 quarters.
  • Levin Capital Strategies's Cantel Medical Corporation position peaked at $509K in Q2 2020.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Levin Capital Strategies's 13F filing for Q1 2021, filed 5 May 2021.